Showing 2691-2700 of 9343 results for "".
- Sernivo Spray Hits Pharmacy Shelveshttps://practicaldermatology.com/news/sernivo-spray-hits-pharmacy-shelves/2458544/Sernivo™ Spray for psoriasis is officially available. Dr. Reddy’s Laboratories’ US subsidiary, Promius Pharma, LLC, U.S. Sernivo™ Spray (betamethasone dipropionate) 0.05% was approved by the Food and Drug Administration (FDA) in February of 2016. The topical steroid spray is indicated for the trea…
- ASDSA Releases New Sun-Safety Model Legislationhttps://practicaldermatology.com/news/asdsa-releases-new-sun-safety-model-legislation/2458548/New model legislation from American Society for Dermatologic Surgery Association (ASDSA) provides state governments with a framework to permit the use of sunscreens in school and camp settings. The ASDSA model legislation – called SUNucate/Reducing the Risk of Skin Cancer and Excessive UV Exposure…
- New Nair Survey Shows Unwanted Body Hair is No Confidence Boosterhttps://practicaldermatology.com/news/new-nair-survey-shows-unwanted-body-hair-is-no-confidence-booster/2458552/Just shy of 80 percent of women are more confident when they do not have unwanted body hair, according to a recent online survey conducted by Harris Poll on behalf of Church & Dwight Co., Inc., the makers of Nair™. Who Wears Short Shorts? Nair for Short Shorts In the survey of 1000 women, 74 perc…
- Novel Topical AD Drug Shows Promise in Phase 2 Studyhttps://practicaldermatology.com/news/novel-ad-drug-shows-promise-in-phase-2-study/2458555/Medimetriks’ MM36 (previously known as OPA-15406) performed well in a Phase 2 trial for the treatment of mild-to-moderate atopic dermatitis, a new study in in Journal of the American Academy of Dermatology shows. The investigational topical phosphodiesterase 4 (PDE4) inhibitor is being developed b…
- Derms on Sunscreen: Do As We Say and As We Dohttps://practicaldermatology.com/news/derms-on-sunscreen-do-as-we-say-and-as-we-do/2458558/Dermatologists are all on the same page when it comes to sunscreen safety and effectiveness, according to a new survey from the National Society for Cutaneous Medicine (NSCM). Fully 99 percent dermatologists agree that regular use of sunscreens helps lower skin cancer risk, and 96 percent consider…
- Clearpath Derm Introduces New Digital Pathology Servicehttps://practicaldermatology.com/news/clear-path-derm-introduces-new-digital-pathology-service/2458560/Clearpath Derm has launched Clearpath 3.0, a digital software solution for dermatopathology. Clearpath 3.0 provides dermatologists with real-time access to whole slide images and patient case information from anywhere using a tablet, iPad or computer. The Clearpath solution leverages images from th…
- AAD Survey: Many Use Sunscreen Incorrectlyhttps://practicaldermatology.com/news/aad-survey-many-use-sunscreen-incorrectly/2458561/Many people don’t understand SPF numbers on product labels, and some may not be using sunscreen properly, which could increase their skin cancer risk, the American Academy of Dermatology reports. In a 2016 survey, only 32 percent of respondents knew that an SPF 30 sunscreen does not provide twice …
- Dr. Brandt's Legacy Lives on with New Dr. Brandt® Skincare Advisory Boardhttps://practicaldermatology.com/news/dr-brandts-legacy-lives-on-with-new-dr-brandt-skincare-advisory-board/2458563/Dr. Brandt® Skincare is rolling out a new Advisory Board to elevate the brand and honor Dr. Brandt’s legacy of innovation in dermatology. Frederick Brandt died on April 5, 2015 in his home in Coconut Grove, Florida. The first two doctors on the new Skincare Advisory Board are New York-based dermat…
- Feet Get Skin Cancer Too, ACFAS Warnshttps://practicaldermatology.com/news/feet-get-skin-cancer-too-acfas-warns/2458565/Skin cancer of the foot is prevalent and can be fatal if not caught early, the American College of Foot and Ankle Surgeons (ACFAS) warns. While all types of skin cancer, including squamous cell and basal cell carcinoma, can be found on the foot, the most common is melanoma. May is National Skin C…
- Alphaeon Launches PROVOQUE™ Facial Serumhttps://practicaldermatology.com/news/alphaeon-launches-provoque-facial-serum/2458567/Alphaeon Corporation has launched PROVOQUE™ Facial Serum to help address the visible signs of skin aging. PROVOQUE Facial Serum is a stem cell-conditioned media containing growth factors secreted by stem cells. Packaged in an easy to apply cosmetic formulation, PROVOQUE Facial Serum is intended to …